| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/1996 | EP0695161A1 Cosmetic and medicinal topical preparations |
| 02/07/1996 | EP0695128A1 Nutrient fats having improved digestibility |
| 02/07/1996 | EP0695127A1 Compositions for administration to animals with coccidiosis |
| 02/07/1996 | EP0695123A1 Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
| 02/07/1996 | EP0637235B1 Oral suspension formulation |
| 02/07/1996 | EP0627915A4 Sprayable analgesic composition and method of use. |
| 02/07/1996 | EP0611368B1 Substituted aminopyrimidines as angiotensin ii antagonists |
| 02/07/1996 | EP0502049B1 Tumour necrosis factor antagonist |
| 02/07/1996 | EP0501975B1 Antihypertensive compositions and use thereof |
| 02/07/1996 | EP0491053B1 Water-soluble bis-dioxopiperazine derivatives with antitumoral properties |
| 02/07/1996 | EP0470251B1 Liquid prostaglandin composition |
| 02/07/1996 | CN1116425A New cephem compounds |
| 02/07/1996 | CN1116406A Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/07/1996 | CN1116206A Platinum complex and malignant tumor treating drug containing the same |
| 02/07/1996 | CN1116204A Processes for the diastereoselective synthesis of nucleosides |
| 02/07/1996 | CN1116200A Tri-lower alkoxy benzene derivatives |
| 02/07/1996 | CN1116109A 赢生口服液 Win Oral Health |
| 02/07/1996 | CN1116095A Mucilage for curing burn |
| 02/07/1996 | CN1116094A Preparation of nutrient heathful composition from 1,6-fructose diphosphate calcium salt or sodium salt |
| 02/07/1996 | CN1116093A Long-effect anodyne |
| 02/07/1996 | CN1116092A Pharmaceutical composition |
| 02/07/1996 | CN1030922C Process for preparation of new amino acid derivatives |
| 02/07/1996 | CN1030920C Process for making mometasone furoate monohydrate |
| 02/07/1996 | CN1030918C Process for preparing 4-substituted alkyl carbapenem antibiotics |
| 02/07/1996 | CN1030917C Process for preparing heterocyclic derivatives |
| 02/07/1996 | CN1030916C Process for preparing hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
| 02/07/1996 | CN1030915C Method for preparation of benzimidazole derivatives |
| 02/07/1996 | CN1030890C Method for preparing a medicament compound |
| 02/06/1996 | US5489698 4-Desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 02/06/1996 | US5489697 Catalytic condensation of ethylbutyryl acetate and phloroglucinol yields 5,7-dihydroxy-4-propylcoumarin which is acetylated at position 8, then reacted with 4,4-dimethoxy-2-methylbutan-2-ol, then treated with acetal and reduced |
| 02/06/1996 | US5489693 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes preparing them |
| 02/06/1996 | US5489691 Cyclization; decyclization; hydrolysis; neutralization; salt formation |
| 02/06/1996 | US5489690 Process for trans-6[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 02/06/1996 | US5489688 Process for preparing trans-piperidine-2,5-dicarboxylates |
| 02/06/1996 | US5489686 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
| 02/06/1996 | US5489680 Carbamates of rapamycin |
| 02/06/1996 | US5489615 Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof |
| 02/06/1996 | US5489614 Medicinal antioxidants used in prevention and treatment of tissue damage induced by lipid peroxidation |
| 02/06/1996 | US5489612 Calixarene chloride-channel blockers |
| 02/06/1996 | US5489611 Method for lowering plasma levels of lipoprotein (a) |
| 02/06/1996 | US5489610 Sustained release organic nitrite therapy |
| 02/06/1996 | US5489609 Liver disorder, hepatitis, antiulcer agent |
| 02/06/1996 | US5489607 Use of enadoline in the treatment of benign prostatic enlargement |
| 02/06/1996 | US5489604 Treating degenerative diseases |
| 02/06/1996 | US5489602 Hypoglycemic and hypolipidemic agents |
| 02/06/1996 | US5489600 Anticholesterol and -lipemic agents; arteriosclerosis; enzyme inhibiors |
| 02/06/1996 | US5489598 Inhibits adhesion of mac-1 to endothelial cells, useful for treating gastritis induced by nonsteroidantiinflammatory drugs imflammatory bowel disease of ulcerative colitis |
| 02/06/1996 | US5489595 Carbamates of rapamycin |
| 02/06/1996 | US5489594 Anticoagulants |
| 02/06/1996 | US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them |
| 02/06/1996 | US5489589 Amino acid derivatives of paclitaxel |
| 02/06/1996 | US5489587 Benzofurans used to inhibit bone loss |
| 02/06/1996 | US5489586 Method for treating inflammatory disease in humans |
| 02/06/1996 | US5489585 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections |
| 02/06/1996 | US5489582 Hypotensive agents |
| 02/06/1996 | US5489581 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 02/06/1996 | US5489579 Potentation of NMDA antagonists |
| 02/06/1996 | US5489576 Therapeutic agent for hemorrhoidal diseases |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/06/1996 | US5489441 Method for suppressing immune response associated with psoriasis, contact dermatitis and diabetes mellitus |
| 02/06/1996 | US5489396 Cleaning/decontaminating liquid compositions based on alkoxylated surfactant mixtures, particularly for emergency sets, and their use |
| 02/06/1996 | CA2152693A1 Therapeutic composition for pancreatitis |
| 02/06/1996 | CA2057456C Anti depression pharmaceutical |
| 02/05/1996 | CA2155245A1 Use of neutortensin antagonists for the preparation of diuretic drugs |
| 02/05/1996 | CA2155153A1 Quinolone- and naphthyridonecarboxylic acid derivatives |
| 02/05/1996 | CA2155148A1 Pyrrolocarbazoles |
| 02/05/1996 | CA2155143A1 Method of promoting hair growth |
| 02/04/1996 | CA2155170A1 Stably storable and readily water soluble composition of cephalosporin for injections |
| 02/04/1996 | CA2155092A1 Benzoxazolyl- and benzothiazolyloxazolidinones |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002609A1 Antioxidant-containing blowing agent |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002557A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002550A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection |
| 02/01/1996 | WO1996002547A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 02/01/1996 | WO1996002546A1 Water-soluble esters of camptothecin compounds |
| 02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | WO1996002544A1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 02/01/1996 | WO1996002541A1 8-aryl-1,6-naphthyridin-5-ones |
| 02/01/1996 | WO1996002537A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 02/01/1996 | WO1996002536A1 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists |
| 02/01/1996 | WO1996002535A1 Process for synthesis of substituted sulphoxides |
| 02/01/1996 | WO1996002534A1 Piperazine thiopyridines for controlling helicobacter bacteria |
| 02/01/1996 | WO1996002525A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 02/01/1996 | WO1996002522A1 Natriuretic and anti-hypertensive compounds |
| 02/01/1996 | WO1996002520A1 Triazole compounds and their use as dopamine-d3-ligands |
| 02/01/1996 | WO1996002519A1 Substituted pyrimidine compounds and their use |
| 02/01/1996 | WO1996002515A1 Heterocyclic- and carbocyclic-substituted benzoic acids and synthesis thereof |
| 02/01/1996 | WO1996002513A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 02/01/1996 | WO1996002512A1 Trifluoromethylquinolinecarboxylic acid derivative |
| 02/01/1996 | WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 02/01/1996 | WO1996002506A1 Quinoline derivatives as leukotriene antagonists |
| 02/01/1996 | WO1996002505A1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 02/01/1996 | WO1996002503A1 Novel compound having platelet aggregation inhibitor effect |
| 02/01/1996 | WO1996002501A1 SYNTHESIS OF 1α-HYDROXY VITAMIN D |